In the news: San Diego Business Journal covers Sinopia’s Seed Financing and Lead Program in Parkinson’s disease
Sinopia Nearing Clinic with Promising Parkinson’s Drug
Eli Walsh, July 9, 2026
Previous
Previous
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
Next
Next